Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2010
10/20/2010CN101862309A Glipizide sustained-release capsule and preparation method thereof
10/20/2010CN101862308A Aeromonas hydrophila micro-capsular oral vaccine
10/20/2010CN101862307A Bisulfate Cefdinir sodium capsule and preparation method thereof
10/20/2010CN101862306A New type slightly soluble oral medicine self-emulsification preparation and preparation method thereof
10/20/2010CN101862305A Ambroxol hydrochloride sustained-release pellet and preparation method
10/20/2010CN101862304A Uncaria sustained-release tablet and preparation method thereof
10/20/2010CN101862303A Roxithromycin sustained release tablets and preparation method thereof
10/20/2010CN101862302A Amlodipine besylate liposome tablet
10/20/2010CN101862301A Tartraric rosiglitazone sustained release tablet and preparation method thereof
10/20/2010CN101862300A Lovastatin dispersible tablet and preparation method thereof
10/20/2010CN101862299A Preparation method of aspoxicillin freeze-dried powder injection
10/20/2010CN101862298A Benproperine phosphate granular formulation
10/20/2010CN101862297A Water-insoluble medicine sustained-release pellet, sustained-release orally disintegrating tablet thereof and preparation method thereof
10/20/2010CN101862296A Cefmetazole sodium composition powder injection for injection
10/20/2010CN101862295A Aggregate having enhanced deformability and including at least three amphipatic substances
10/20/2010CN101862294A Ivermectin suspending agent, preparation method and application thereof
10/20/2010CN101862293A Doxycycline hydrochloride oil turbid liquor, preparation method and application thereof
10/20/2010CN101862292A Ibuprofen suspension
10/20/2010CN101862291A Bone induction gel
10/20/2010CN101862233A Drug-delivery endovascular stent and method for treating restenosis
10/20/2010CN101485736B Medicament composition with stone-eliminating and expelling functions and preparation method thereof
10/20/2010CN101361825B Traditional Chinese medicine formulation for treating alopecia
10/20/2010CN101357116B Transdermal and transmucosal local narcotic analgesic and preparation method of gel formulation thereof
10/20/2010CN101342194B Traditional Chinese medicine preparation for treating median or late-stage malignant tumors, chronic hepatitis B, and preparation method thereof
10/20/2010CN101301456B Compound Marsdenia tenacissima capsules
10/20/2010CN101297948B Chinese medicine lotion preparation for treating chest wall soft tissue injury
10/20/2010CN101284054B Externally-applied drug for treating insomnia
10/20/2010CN101279027B Chinese medicine lotion preparation for curing acute conjunctivitis
10/20/2010CN101249181B Removing blood stasis Tongmai Chinese medicine compound preparations and method of preparing the same
10/20/2010CN101244258B Use of TAT-N25 polypeptide in treating cell growth exception dermatosis such as psoriasis
10/20/2010CN101234148B Pure Chinese medicine powder for treating bedsore, scald and burn
10/20/2010CN101167707B New use of protocatechuic aldehyde
10/20/2010CN101164530B Aqueous solution containing stable sodium pyrouvate and preparing method and use thereof
10/20/2010CN101134040B Application of forsythiaside in the preparation of medicament for treating or preventing acute and chronic liver damnification and liver fibrosis
10/20/2010CN101060834B Small particle copper pyrithione
10/19/2010US7816412 Mixture of monomer, promoter, solvent and crosslinking agent; skin contact adhesive
10/19/2010US7816409 comprising a fluoroether anesthetic compound selected from sevoflurane, desflurane, isoflurane, enflurane and methoxyflurane, and at least one stabilizer agent selected from propylene glycol, polyethylene glycol, hexylene glycol, 1,3-butylene glycol and a saturated cyclic alcohol preferably menthol
10/19/2010US7816374 Administering to respiratory system an effective amount of a topical anesthetic, such as lidocaine, or a pharmaceutically acceptable salt thereof; chronic obstructive pulmonary disease
10/19/2010US7816373 administering polyethylene glycol or ethylene oxide-propylene oxide copolymers, with drugs, to improve delivery in the alimentary canal
10/19/2010US7816342 Anti-obesity compositions
10/19/2010US7816341 Edible products, soft and hard capsules
10/19/2010US7816327 Topical administration for therapy of exposure to urushiol; irritating oils such as catechol-containing plant-derived antigens such as poison ivy, poison oak, poison sumac and Asian lacquer tree and oils containing capsaicin
10/19/2010US7816319 Methods and products for manipulating uncoupling protein expression
10/19/2010US7816316 hydrogel of hyaluronic acid derivative chemically crosslinked in solution in presence of pharmacologically active protein or peptide dissolved therein via dithiothreitol
10/19/2010US7816292 based on silicon, boron, and phosphorus; plasma enhanced chemical vapor deposition
10/19/2010US7816149 comprises a selectively coated quantum dot having selected band gap energies, characteristic absorption, emission spectra and outer coatings for therapy and diagnostic purposes in biophotonics and nanomedicine
10/19/2010US7816006 Non-stoichiometric nanomaterial compositions with distinctive shape and morphology
10/19/2010US7815949 treating hot flashes in a post-menopausal female patient with the plant extracts; phytoestrogens for replace hormone replacement therapy; insomnia, vaginal dryness, decreased libido, and urinary incontinence; treating breast and/or uterine cancer, and osteoporosis
10/19/2010US7815942 selective irreversible inhibitor of the B-form of the enzyme monoamine oxidase used, for example, for the treatment of Parkinson's disease; R(+)-N-propargyl-1-aminoindan salts, in particular tartrate, esylate, mesylate, or sulfate salts
10/19/2010US7815941 Nucleic acid microspheres, production and delivery thereof
10/19/2010US7815940 Gastric acid secretion inhibiting composition
10/19/2010US7815939 microparticles containing solifenacin or a salt thereof and polyethylene glycol which are present in a homogeneously mixed state are coated with a film comprising a water-soluble polymer, such as hydroxypropylmethylcellulose; quickly disintegrating; no unpleasant taste
10/19/2010US7815938 Film coating
10/19/2010US7815937 Liquiflash particles and an excipient mass; friability of less than 1%; need for conventional super disintegrant and having a friability of less than 1%; no need for conventional superdisintegrant
10/19/2010US7815936 Using as carriers of pharmaceutical active constituents and/or auxiliary substances
10/19/2010US7815935 Orally distintegrating formulation and process for preparing the same
10/19/2010US7815934 Sequestering subunit and related compositions and methods
10/19/2010US7815933 Pre-concentrate emulsion of a nitrogen oxide-releasing NSAID, a surfactant, and an oil or fat, for oral administration; forming an oil-in-water emulsion with gastrointestinal fluids; side- effect reduction; bioavailability; treating pain and inflammation
10/19/2010US7815932 drug layer, support layer insoluble in water comprising ethyl cellulose and hydroxypropyl methylcellulose, backing on support layer, wherein drug layer consists of fentanyl or salt as active ingredient, methyl vinyl ether-maleic anhydride copolymer as adhesive, hydroxypropylcellulose; easily removed
10/19/2010US7815928 assembly for implantation and insertion of a solid or semi-solid formulation into a precise depot site of a patient's body such that formulation is able to persist for a certain period in the site, the assembly comprising:a solid or semi-solid formulation containing at least one active principle
10/19/2010US7815924 Cosmetic composition containing microcrystalline cellulose
10/19/2010US7815922 Articles having bioactive surfaces and solvent-free methods of preparation thereof
10/19/2010US7815914 methods of identifying susceptibility of cells to reovirus infection by measuring constitutive ras-MAP signaling; provides for reovirus treatment of mammals to treat proliferative disorders including breast tumors, a subset of tumors in which mutation of ras gene is not believed to play significant role
10/19/2010US7815898 Continuous slow release of a oral drug containing phosphorus binder such as polyallylamine HCL, polyallylamine carbonate, lanthanum carbonate, Al/OH/3, magnesium acetate, MgCO3, CaCO3, calcium acetate, calcium citrate, calcium alginate, styrene-divinylbenzene copolymer, chitosan for hyperphosphatemia
10/19/2010US7815897 comprising 0.5% by weight to 10% by weight menthol, 0.5% by weight to 10% by weight eucalyptus oil, and an effervescent agent comprising an acid and a base, wherein the tablet dissolves in water having a temperature of at least 38 degrees C. to form a clear solution; mouthwashes
10/19/2010US7815893 formed via reductive amination with O-[2-(2-aminooxy-ethoxy)-ethyl]-hydroxyl amine; conjugated to erythropoietin
10/19/2010US7815615 Implantable fluid delivery apparatuses and implantable electrode
10/19/2010US7815602 External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities
10/19/2010US7815426 Apparatus for forming ultrafine particles
10/19/2010US7814810 Shifter with actuator incorporating shape memory alloy
10/19/2010CA2478407C Polyvinyl acetate film coatings with controlled release and high stability
10/19/2010CA2474934C Rapidly soluble film covering based on polyvinylalcohol-polyether graft copolymers combined with components containing hydroxyl, amide, or ester functions
10/19/2010CA2474634C Stable pharmaceutical composition useful for treating gastrointestinal disorders
10/19/2010CA2470376C Uniform microcapsules
10/19/2010CA2458853C Use of fucans in the treatment of adhesions, arthritis and psoriasis
10/19/2010CA2456547C Process for preparing inhalable powders
10/19/2010CA2455261C Sprinkling method for preparing powder formulations
10/19/2010CA2429138C Sol-fusin: use of gp64-6his to catalyze membrane fusion
10/19/2010CA2427282C Mixtures or organic compounds for the treatment of airway diseases
10/19/2010CA2416512C Enhancement of the action of anti-infective agents
10/19/2010CA2411590C Glycopeptide phosphonate derivatives
10/19/2010CA2400650C Compositions for preventing and treating digestive diseases
10/19/2010CA2380022C Aromatic esters of camptothecins and methods to treat cancers
10/19/2010CA2335913C Use of iso-osmotic saline solutions, method for preparing same and cerumenolytic medicines based on said solutions
10/19/2010CA2286837C Aqueous compositions comprising a lipid and a lanolin-derived surfactant, and their use
10/19/2010CA2241179C Dry compositions
10/19/2010CA2147499C Prostate-specific membrane antigen
10/16/2010CA2700794A1 Emulsifier comprising glycerin-modified organopolysiloxanes
10/15/2010WO2009126950A2 Diterpene glycosides as natural solubilizers
10/15/2010CA2758122A1 Diterpene glycosides as natural solubilizers
10/14/2010WO2010118435A2 Par-1 activation by metalloproteinase-1 (mmp-1)
10/14/2010WO2010118345A1 Improved collagen dispersion and method of producing same
10/14/2010WO2010118339A2 Formulations of indole-3-carbinol derived antitumor agents with increased oral bioavailability
10/14/2010WO2010118265A1 Non-pegylated liposomal doxorubicin triple combination therapy
10/14/2010WO2010118238A2 Controlled release devices and methods for delivery of nucleic acids
10/14/2010WO2010118228A1 Drug delivery composition
10/14/2010WO2010118213A2 Particles for delivery of nucleic acids and related devices and methods
10/14/2010WO2010118200A2 Liposomal formulations of tocopheryl amides
10/14/2010WO2010118050A1 Use of improved toluidine blue in photodynamic therapy
10/14/2010WO2010117957A2 Methods and materials for delivering molecules
1 ... 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 ... 2991